Oxidative stress-inducing carbonyl compounds from common foods: Novel mediators of cellular dysfunction

Molecular Medicine

Volumn 8, Issue 7, 2002, Pages 337-346

  Cai, Weijing ^a   Gao, Qiao Di ^a   Zhu, Li ^a   Peppa, Melpomeni ^a   He, Cijiang ^a   Vlassara, Helen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; ANTIBODY; BOVINE SERUM ALBUMIN; CARBONYL DERIVATIVE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN; METHYLGLYOXAL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; DEPLETION; DIABETES MELLITUS; DIET; ENDOTHELIUM CELL; ENZYME ACTIVITY; FOOD COMPOSITION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; TEMPERATURE; UMBILICAL VEIN;

EID: 0036428823     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402014     Document Type: Article

References (50)

1. Brownlee M, Cerami A, Vlassara H. (1988) Advanced glycosylation endproducts in tissue and biochemical basis of diabetic complications. N. Eng. J. Med. 318: 1315-1321.
2. II in neonatal mesangial cells. Am. J. Physiol. Renal Physiol. 278: F676-F683.
3. ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 272: 17810-17814.
4. Esposito S, Gerlach H, Brett J, et al. (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permerbility and modulation of cell surface coagulant properties. J. Exp. Med. 170: 1387-1407.
5. Schmidt AM, Hori O, Chen J, et al. (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J. Clin. Invest. 96: 1395-1403.
6. Vlassara H, Fuh H, Donnelly T, Cybulaky M. (1995) Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits. Mol. Med. 1(4): 447-456.
7. Hamada Y, Araki N, Koh N, et al. (1996) Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem. Biophys. Res. Commun. 228: 539-543.
8. Hazen SL, Heinecke JW. (1997) 3-Chlorotyrosine: A specific marker of meloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99: 2075-2081.
9. Baynes JW, Thorpe SR. (1999) Role of oxidative stress in diabetic complications, a new perspective on an old paradigm. Diabetes 48: 1-9.
10. Thornalley PJ. (1996) Pharmacology of methylglyoxal. Gen. Pharmacol. 27: 565-573.
11. Thornalley PJ, Hoop NI, Jennings PE, et al. (1989) The human red blood glyoxalas system in diabetes mellitus. Diabetes Res. Clin. Pract. 7: 115-120.
12. Bucala R, Makita Z, Koschinsky T, et al. (1993) Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA 90: 6634-6638.
13. Requena JR, Ahmed MU, Fountain CW, et al. (1997) Carboxymethylethanolamine: A biomarker of phospholipid modification during the maillard reaction in vivo. J. Biol. Chem. 272: 17473-17479.
14. ε-(Carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271: 9982-9986.
15. Thorpe SR, Baynes JW. (1996) Role of the maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging. 9: 69-77.
16. Li YM, Steffes M, Donnelly T, et al. (1996) Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc. Natl. Acad. Sci. USA 93: 3902-3907.
17. Vlassara H. (2001) The AGE-receptor in the pathogenesis of diabeteic complications. Diabetes Metab. Res. Rev. 17: 436-443.
18. Lee TC, Kimiagar M, Pintauro SJ, Chichester CO. (1981) Physiological and safety aspects of maillard browning of foods. Prog. Fd. Nutr. Sci. 5: 243-256.
19. O'Brien J. (1989) Nutritional and toxicological aspects of the maillard browning reaction in foods. Critical Reviews in Food Science and Nutrition 28: 211-248.
20. Koschinsky T, He C, Mitsuhashi T, et al. (1997) Orally absorbed reactive glycation products (Glycotoxins): An environmental risk factor in diabetic nephropathy. Proc. Natl. Acad. Sci. USA 94: 6474-6479.
21. He C, Sabol J, Mitsuhashi T, Vlassara H. (1999) Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes 48: 1308-1315.
22. Lin RY, Reis ED, Dore AT, et al. Lowering of dietary advanced glycation endoproducts (AGE) reduces neointimal formation-after arterial injury in genetically hypercholesterolemic mice. Atherosclerosis (in press).
23. Zheng F, He C, Cai W, et al. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diab./Met. Res. Rev. (in press).
24. Hofmann S, Dong HJ, Zhu L, et al. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in th db/db mouse. Diabetes (in press).
25. Vlassara H, Cai W, Crandall J, et al. Inflamatory Markers are Induced by Dietary Glycotoxins: A Pathway for Accelerated Atherosclerosis in Diabetes. (submitted).
26. Oya T, Hattori N, MizunoY, et al. (1999) Methylglyoxal modification of protein. J. Biol. Chem. 274: 18492-18502.
27. Horie K, Miyata T, Meada K, et al. (1997) Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lessions. J. Clin. Invest. 100: 2995-3004.
28. Droge W, Schulzeosthoff K, Mihm S, et al. (1994) Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8: 1131-1138.
29. Knoepfel L, Steinkuhler C, Carri MT, Rotilio G. (1994) Role of zinc-coordination and of the glutathione redox couple in the redox susceptibility of human transcription factor Sp1. Biochem. Biophys. Res. Commun. 201: 871-877.
30. Mitsuhashi T, Li YM, Fishbane S, Vlassara H. (1997) Depletion of reactive advanced glycation endoproducts from diabetic uremic sera using a lysozyme-linked matrix. J. Clin. Invest. 100: 847-854.
31. 2α from low density lipoprotein during its in vitro oxidation. Prostaglandins, Leukotrienes and Essential Fatty Acids. 62: 217-224.
32. Bucala R, Makita Z, Vega G, et al. (1994) Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA 91: 9441-9445.
33. Founds HW, Sadeghi H. (1999) Monoclonal antibodies specific for advanced glycoxylation endproducts in biological samples. Patent Applicant: ALTEON, Inc., Ramsey, NJ, US5892000.
34. Mellinghoff AC, Reininger AJ, Wuerth JP, et al. (1997) Fromation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity. Diabetes Med. 14: 832-836.
35. Mitsuhashi T, Vlassara H, Founds HW, Li YM. (1997) Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. J. Immunol. Med. 207: 79-88.
36. Li YM, Mitsuhashi T, Wojciechowicz D, et al. (1996) Molecular identity and cellular distribution of advanced glycation endproduct receptors: Relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl. Acad. Sci. USA 93: 11047-11052.
37. Stitt AW, He C, Vlassara H. (1999) Characterization of the advanced glycation end-products receptor complex in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 256: 549-556.
38. Shamsi FA, Partal A, Sady C, et al. (1998) Immunological evidence for methylglyoxal-derived modifications in vivo. J. Biol. Chem. 273: 6928-6936.
39. Che W, Asahi M, Takahashi M, et al. (1997) Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. J. Biol. Chem. 272: 18453-18459.
40. Choudhary D, Chandra D, Kale RK. (1997) Influence of methylglyoxal on antioxidant enzymes and oxidative damage. Toxicol. Lett. 93: 141-152.
41. Odani H, Shinzato T, Usami J, et al. (1998) Imidazolium crosslinks derived from reaction of lysine with glyoxal and methylglyoxal are increased in serum proteins of uremic patients: Evidence for increased oxidative stress in uremia. FEBS. Letters 427: 381-385.
42. Okado A, Kawasaki Y, Hasuike Y, et al. (1996) Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem. Biophys. Res. Commun. 225: 219-224.
43. Lyons TJ, Jenkins AJ. (1997) Lipoprotein glycation and its metabolic consequence. Cur. Opin. Lipidol. 8: 174-180.
44. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004.
45. Vlassara H, Li YM, Imani F, et al. (1995) Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): A new member of AGE-receptor complex. Mol. Med. 1(6): 634-646.
46. Araki N, Higashi T, Mori T, et al. (1995) Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the maillard reaction. Eur. J. Biochem. 230: 408-415.
47. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP. (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovascular Research 37: 586-600.
48. Giardino I, Fard AK, Hatchell DL, Brownlee M. (1998) Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47: 1114-1120.
49. Rattan, AK, Arad Y. (1998) Temporal and kinetic determinants of the inhibiter of LDL oxidation by N-acetylcysteine (NAC). Atherosclerosis 138: 319-327.
50. Perchellet EM, Maatta EA, Abney NL, Perchellet JP. (1987) Effects of diverse intracellular thiol delivery agents on gluthathione peroxidase activity, the ratio of reduced/oxidized gluthathione, and ornithine decarboxylase induction in isolated mouse epidermal cells treated with 12-0-tetradecanoylphorbol-13-acetate. J. Cell Physiol. 131: 64-73.